Prudential Financial Inc Bio N Tech Se Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$88.96 - $112.35 $60,848 - $76,847	-684 Reduced 22.49%	2,358 $217,000
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $276,548 - $342,985	3,042 New	3,042 $321,000
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $1.09 Million - $2 Million	-8,611 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $3.14 Million - $5.26 Million	-14,500 Reduced 62.74%	8,611 $2 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $102,965 - $223,615	-500 Reduced 2.12%	23,111 $6.31 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $158,648 - $338,086	1,400 Added 6.3%	23,611 $5.29 Million
Q1 2021 May 12, 2021	BUY	$85.73 - $119.5 $1.9 Million - $2.65 Million	22,211 New	22,211 $2.43 Million

360

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.